MoneyWorks4Me

MPS Pharmaa - Quaterly Results

12 Aug 2025 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2025 is Rs. -2.20 millions as compared to Net Loss of Rs. -2.23 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -1.92% as compared to -1.93% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.04 0.00 0.00 0.04 0.00 0.48 0.94 -48.94
PBIDT -1.92 -1.93 -0.52 -1.92 -1.93 -0.52 -7.17 -7.05 1.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PBDT -1.92 -1.93 -0.52 -1.92 -1.93 -0.52 -7.18 -7.06 1.70
Depreciation 0.37 0.37 0.00 0.37 0.37 0.00 1.47 1.47 0.00
PBT -2.29 -2.30 -0.43 -2.29 -2.30 -0.43 -8.65 -8.53 1.41
TAX -0.09 -0.07 28.57 -0.09 -0.07 28.57 0.34 -0.22 -254.55
Deferred Tax -0.09 -0.07 28.57 -0.09 -0.07 28.57 0.00 -0.22 -100.00
PAT -2.20 -2.23 -1.35 -2.20 -2.23 -1.35 -8.99 -8.31 8.18
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..